Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How ResMed Trounced Expectations in Q4

TheMotleyFool

0 0

There were plenty of questions earlier this year about how the COVID-19 pandemic might impact ResMed (NYSE: RMD). It's fair to say that most of the concerns have been put to rest. ResMed's shares are up more than 20% year to date.

The company announced its fiscal 2020 fourth-quarter results after the market closed on Wednesday. Here are the highlights from ResMed's Q4 update.

Image Source: Getty Images.

Source Fool.com

Like: 0

RMD

Share